{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:57:34Z","timestamp":1767650254645,"version":"3.44.0"},"reference-count":6,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"published-print":{"date-parts":[[1994,11]]},"abstract":"<jats:p>A preterm baby, whose mother received chemotherapy for acute leukaemia during pregnancy, required intensive care because of profound anaemia and neutropenia. Haemopoietic progenitor cell studies showed fetal marrow suppression. Those caring for such mothers and babies should know the possible serious effects chemotherapy for malignancies can have on a developing fetus. Long term follow up of the baby is imperative.<\/jats:p>","DOI":"10.1136\/fn.71.3.f209","type":"journal-article","created":{"date-parts":[[2008,10,31]],"date-time":"2008-10-31T17:55:51Z","timestamp":1225475751000},"page":"F209-F210","source":"Crossref","is-referenced-by-count":29,"title":["Fetal marrow suppression after maternal chemotherapy for leukaemia."],"prefix":"10.1136","volume":"71","author":[{"given":"N A","family":"Murray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Acolet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Deane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I A","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1994,11,1]]},"reference":[{"key":"ref_1","first-page":"23","article-title":"Pregnancy and maternal malignant haematological disorders","volume-title":"haematological problems","author":"Slade, R.; James, D.K.","year":"1991","unstructured":"Slade R, James DK. Pregnancy and maternal malignant haematological disorders. In: Turner TL, ed. Perinatal haematological problems. Chichester: John Wiley & Sons Ltd, 1991: 23-38."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.2830360404","article-title":"Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 children","volume":"36","author":"Aviles, A.; Dias-Maqueo, J.C.; Talavera, A.; Guzman, R.; Garcia, E.L.","year":"1991","unstructured":"Aviles A, Dias-Maqueo JC, Talavera A, Guzman R, Garcia EL. Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 children. Am I Hematol 1991; 36: 243-8.","journal-title":"Am I Hematol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/jcp.32.7.666","article-title":"Erythroid progenitors (BFU-e and CFU-e) in acute leukemia","volume":"32","author":"MJ, Urabe A.Murphy; M, Haghbin; TS, Gee","year":"1979","unstructured":"Urabe A. Murphy MJ, Haghbin M, Gee TS. Erythroid progenitors (BFU-e and CFU-e) in acute leukemia. Jf Clin Pathol 1979; 32: 666-9.","journal-title":"Jf Clin Pathol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2257.1989.tb00205.x","article-title":"Combination chemotherapy with conservative obstetric management in the treatment ofpregnant patients with acute myeloblastic leukemia","volume":"11","author":"Roy, V.; Gutteridge, C.N.; Nysenbaum, A.; Newland, A.C.","year":"1989","unstructured":"Roy V, Gutteridge CN, Nysenbaum A, Newland AC. Combination chemotherapy with conservative obstetric management in the treatment ofpregnant patients with acute myeloblastic leukemia. Clin Lab Haematol 1989; 11: 171-8.","journal-title":"Clin Lab Haematol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1471-0528.1989.tb03389.x","article-title":"Transplacental effects of maternal cancer chemotherapy. Case report","volume":"96","author":"Raffles, A.; Williams, J.; Costello, K.; Clark, P.","year":"1989","unstructured":"Raffles A, Williams J, Costello K, Clark P. Transplacental effects of maternal cancer chemotherapy. Case report. BrJ Obstet Gynaecol 1989; 96: 1099-100.","journal-title":"BrJ Obstet Gynaecol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0140-6736(91)90490-G","article-title":"Increased risk of myelodysplasia and leukemia after etoposide, cisplatin, and bleomycin for germ-cell tumours","volume":"338","author":"Pedersen-Bjergaard, J.; Daugaard, G.; Hansen, S.W.; Philip, P.; Larsen, S.O.; Rorth, M.","year":"1991","unstructured":"Pedersen-Bjergaard J, Daugaard G, Hansen SW, Philip P, Larsen SO, Rorth M. Increased risk of myelodysplasia and leukemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet 1991; 338: 359-63.","journal-title":"Lancet"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/fn.71.3.F209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T10:32:52Z","timestamp":1757068372000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/fn.71.3.F209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,11]]},"references-count":6,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1994,11,1]]},"published-print":{"date-parts":[[1994,11]]}},"alternative-id":["10.1136\/fn.71.3.F209"],"URL":"https:\/\/doi.org\/10.1136\/fn.71.3.f209","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"type":"print","value":"1359-2998"},{"type":"electronic","value":"1468-2052"}],"subject":[],"published":{"date-parts":[[1994,11]]}}}